Company intelligence / Profile preview

OneKind

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

OneKind Science is a biotechnology company specializing in human-centric artificial intelligence to advance precision medicine and longevity. The company utilizes its proprietary MAPLE (Multimodal AI Platform for Life Sciences) to integrate diverse biological and clinical datasets, facilitating the discovery of novel therapeutic targets and biomarkers. OneKind Science focuses on 'The Science of One,' aiming to deliver highly personalized healthcare solutions and optimize drug development through strategic partnerships and licensing. Its research spans across oncology, neurodegeneration, and age-related diseases.

Therapeutic areas: OncologyNeurologyOther
Modalities: Small moleculeBiologicmRNA-based drugs
Industry: Biotech

Beyond the preview

Go deeper on OneKind.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OneKind.

Explore the full profile